样式: 排序: IF: - GO 导出 标记为已读
-
What I see, what you say: How cross‐method variation sharpens characterization of irritability in early childhood Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-03-14 Alyssa J. Parker, Peyton Brock, Maria Kryza‐Lacombe, Margaret Briggs‐Gowan, Lea R. Dougherty, Lauren S. Wakschlag, Jillian Lee Wiggins
ObjectivesIdentification of clinically significant irritability in preschool age is important to implement effective interventions. However, varying informant and measurement methods display distinct patterns. These patterns are associated with concurrent and future mental health concerns. Patterns across multi‐informant methods in early‐childhood irritability may have clinical utility, identifying
-
Assessing gambling disorder using frequency‐ and time‐based response options: A Rasch analysis of the gambling disorder identification test Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-03-13 Olof Molander, Peter Wennberg, Nicki A. Dowling, Anne H. Berman
ObjectivesThe Gambling Disorder Identification Test (GDIT) is a recently developed self‐report measure. The GDIT includes items with multiple response options that are either based on frequency or time, and item response theory evaluations of these could yield vital knowledge on its measurement performance.MethodsThe GDIT was evaluated using Rasch analysis in a study involving 597 Swedish gamblers
-
Investigating the psychometric properties of PaRCADS—Parenting to Reduce Child Anxiety and Depression Scale in a Norwegian sample Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-03-09 Kristin Ytreland, Jo Magne Ingul, Stian Lydersen, Marie Bee Hui Yap, Wan Hua Sim, Anne Mari Sund, Elisabeth Valmyr Bania
ObjectivesParents play a pivotal role in child development and several parental factors have been identified as risk or protective factors for childhood anxiety and depression. To assess and target these parental factors in interventions, there is a need for a comprehensive, easy‐to‐use instrument.MethodThis study aimed to investigate the psychometric properties of an adapted version of the Parenting
-
The effectiveness and tolerability of trauma‐focused psychotherapies for psychotic symptoms: A systematic review of trauma‐focused psychotherapies Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-03-05 Jordan Reid, Charles Cole, Nabeela Malik, Vaughan Bell, Michael Bloomfield
IntroductionPsychological trauma is an established risk factor for psychosis. Trauma‐focused psychotherapies (TFPT) have been suggested as a potential treatment for reducing psychotic symptoms in those who have experienced trauma. We therefore sought to investigate the effectiveness, tolerability, and acceptability of TFPT for psychotic symptoms.MethodsWe conducted a systematic review of studies of
-
Psychometrics of rating scales for externalizing disorders in Japanese outpatients: The ADHD-Rating Scale-5 and the Disruptive Behavior Disorders Rating Scale Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-02-16 Saeko Ishibashi, Takeshi Nishiyama, Takuya Makino, Futoshi Suzuki, Shoko Shimada, Shinji Tomari, Eiji Imanari, Takuma Higashi, Shintaro Fukumoto, Sawa Kurata, Yoshifumi Mizuno, Takeshi Morimoto, Hidetaka Nakamichi, Tomoko Iida, Kei Ohashi, Atsurou Yamada, Takuma Kimura, Yukiko Kuru, Satoshi Sumi, Yasuo Tanaka, Kazuya Ono, Hironobu Ichikawa, George J. DuPaul, Hirotaka Kosaka
This study validated the Japanese version of the Attention-Deficit/Hyperactivity Disorder-Rating Scale-5 (ADHD-RS-5) and the Disruptive Behavior Disorders Rating Scale. We extended the ADHD-RS-5 by adding the oppositional defiant disorder and conduct disorder subscales to compare the two rating scales psychometrically.
-
New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-02-13 Elin Dahlén, Carola Bardage, Paulina Tuvendal, Rickard Ljung
Anxiety and sleep disorders are common in the population and anxiolytics and sedatives are widely used. Our aim was to describe the drug utilization of new users of anxiolytics and sedatives in adults including type of drug, doses, prescribers' characteristics, and psychiatric comorbidity.
-
Heightened facial muscle reactivity in preadolescent girls with pathological anxiety Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-01-31 Joshua R. Cruz, Amy Cochran, Daniel R. McFarlin, Lisa E. Williams, Ned H. Kalin
Anticipatory anxiety and heightened responses to uncertainty are central features of anxiety disorders (ADs) that contribute to clinical impairment. Anxiety symptoms typically emerge during childhood, and even subthreshold-AD symptoms are associated with distress and risk for future psychopathology. This study compared facial emotional response to threat and uncertainty between preadolescent girls
-
Validation and normative data on the Revised Child Anxiety and Depression Scale RCADS-25 in a Swedish national probability sample of children and adolescents aged 4–17 years Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-01-24 Anders Carlander, Sophie Cassel, Malin J-Son Höök, Oskar Lundgren, Marie Löf
Mental health problems among children and adolescents are a growing public health concern. Self-report questionnaires are pivotal for screening and early detection of mental health issues. We evaluate the psychometric properties and provide norm data of the 25-item child and 25-item parent-report versions of the Revised Child Anxiety and Depression Scale (RCADS).
-
Mental and Substance Use Disorders Prevalence Study: Background and Methods Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-01-22 Heidi Guyer, Heather Ringeisen, Jill Dever, Dan Liao, Andy Peytchev, Christine Carr, Paul Geiger, Leyla Stambaugh, Tim Smith, Lisa Dixon, Mark Olfson, Michael First, Scott Stroup, Lydia Chwastiak, Maria Monroe-Devita, Jeff Swanson, Marvin Swartz, Ronald C. Kessler, Robert Gibbons, Natalie Bareis, Elizabeth Sinclair Hancq, Thomas Clarke, Mark Edlund
The Mental and Substance Use Disorders Prevalence Study (MDPS) builds upon previous epidemiologic studies to provide estimates of prevalence and treatment rates of mental and substance use disorders among adults aged 18–65 in the U.S. The study background and methods are described.
-
Harmonisation of assessments of attention, social, emotional, and behaviour problems using the Child Behavior Checklist and the Strengths and Difficulties Questionnaire Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2024-01-12 Nicole Baumann, Peter J. Anderson, Samantha Johnson, Neil Marlow, Dieter Wolke, Julia Jaekel
Retrospective harmonisation of data obtained through different instruments creates measurement error, even if the underlying concepts are assumed the same. We tested a novel method for item-level data harmonisation of two widely used instruments that measure emotional and behavioural problems: the Child Behavior Checklist (CBCL) and the Strengths and Difficulties Questionnaire (SDQ).
-
The Diagnostic Interview for Sexual Dysfunctions in Women for DSM-5 and ICD-11: Development and initial validation using a vignette-based approach Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-12-28 Rebekka Schwesig, Julia Velten, Jürgen Hoyer
The aim of this study was to evaluate the psychometric properties of the newly developed Diagnostic Interview for Sexual Dysfunctions in Women (DISEX-F), which covers diagnostic criteria of DSM-5 and ICD-11.
-
Proof-of-concept of a data-driven approach to estimate the associations of comorbid mental and physical disorders with global health-related disability Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-12-29 Ymkje Anna de Vries, Jordi Alonso, Somnath Chatterji, Peter de Jonge, Joran Lokkerbol, John J. McGrath, Maria V. Petukhova, Nancy A. Sampson, Erik Sverdrup, Daniel V. Vigo, Stefan Wager, Ali Al-Hamzawi, Guilherme Borges, Ronny Bruffaerts, Brendan Bunting, Stephanie Chardoul, Elie G. Karam, Andrzej Kiejna, Viviane Kovess-Masfety, Fernando Navarro-Mateu, Akin Ojagbemi, Marina Piazza, José Posada-Villa
The standard method of generating disorder-specific disability scores has lay raters make rankings between pairs of disorders based on brief disorder vignettes. This method introduces bias due to differential rater knowledge of disorders and inability to disentangle the disability due to disorders from the disability due to comorbidities.
-
Issue Information Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-12-28
No abstract is available for this article.
-
Development, psychometric evaluation, and factor analysis of an instrument measuring quality of life in autistic preschoolers Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-12-22 Jérôme Lichtlé, Emmanuel Devouche, Isaora Zefania Dialahy, Aude de Gaulmyn, Anouck Amestoy, Romain Coutelle, Pascale Isnard, Jean-Louis Monestès, Laurent Mottron, Emilie Cappe
Early interventions for autistic children should target their quality of life (QoL) but require adapted measures. The association of a child's temperament and parental characteristics with the QoL of autistic children remains unknown.
-
Issue Information Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-12-06
No abstract is available for this article.
-
The three-dimensional community structure of attention-deficit hyperactivity disorder (ADHD) traits captured by the Adult ADHD Self-Report Scale: An exploratory graph analysis Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-11-27 Maria Panagiotidi, Orestis Zavlis, Myles Jones, Tom Stafford
To employ a novel analytic method—namely, exploratory graph analysis (EGA)—to subclinical attention-deficit hyperactivity disorder (ADHD) trait scores in order to reveal their dimensional structure, as well as compare EGA's performance with traditional factor-analytic techniques in doing so.
-
Issue Information Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-11-17
No abstract is available for this article.
-
Characteristics and prediction of risky gambling behaviour study: A study protocol Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-11-04 Robert Czernecka, Theresa Wirkus, Gerhard Bühringer, Anja Kräplin
This study protocol describes the RIGAB study, a prospective case-control-study assessing online sports betting behaviour and underlying risk factors for the development of gambling disorder (GD). It has two aims: (1) to characterise sports bettors concerning putative risk factors and their gambling behaviour, and (2) to predict the development of GD from these factors.
-
Commentary on the special issue: Leveraging measurement to refine developmental perspectives on psychopathology Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-10-31 Daniel S. Pine
1 INTRODUCTION This Special Issue of International Journal of Methods in Psychiatric Research highlights developmental perspectives on irritability and related dimensions of psychopathology. The issue's papers (Alam et al., 2023; Hirsch et al., 2023; Kirk et al., 2023; Wakschlag et al., 2023; Wigg et al., 2023; Wiggins et al., 2023a, 2023b) extend a solid foundation of research to target questions
-
Parent-child agreement on children's psychopathology and the impact of parental depression Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-10-23 Johanna Löchner, Stephanie Hämmerle, Sarah Ghezih, Kornelija Starman-Wöhrle, Gerd Schulte-Körne, Belinda Platt
Parental depression increases children's risk of mental illness and may simultaneously impair the detection of children's symptoms. Here we investigate the nature of parent-child agreement of children's psychopathology in children of parents with current (cMD) versus remitted (rMD) major depression.
-
Modeling the normal:abnormal spectrum of early childhood internalizing behaviors: A clinical-developmental approach for the Multidimensional Assessment Profiles Internalizing Dimensions Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-10-10 Lauren S. Wakschlag, Phillip Sherlock, Courtney K. Blackwell, James L. Burns, Sheila Krogh-Jespersen, Richard C. Gershon, David Cella, Kristin A. Buss, Joan L. Luby
We expanded the Multidimensional Assessment Profiles (MAPS) Scales developmental specification model to characterize the normal:abnormal spectrum of internalizing (anxious and depressive) behaviors in early childhood via the MAPS-Internalizing (MAPS-INT) scale.
-
Characterizing the spectrum of irritability in preadolescence: Dimensional and pragmatic applications Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-10-06 Tasmia Alam, Nathan Kirk, Emily Hirsch, Margaret Briggs-Gowan, Lauren S. Wakschlag, Amy Krain Roy, Jillian Lee Wiggins
Characterize the dimensional spectrum of preadolescent (PA) irritability, a robust transdiagnostic vulnerability marker, using the youth version of the Multidimensional Assessment Profiles Temper Loss (MAPS-TL-Youth) scale including common and with developmentally specific items. Based on this, derive and validate a clinically optimized irritability screener to flag psychopathology risk in preadolescents
-
Young people's future thinking and mental health: The development and validation of the Adolescent Future Thinking Rating Scale Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-10-03 Peiyao Tang, Edmund Sonuga-Barke, Katarzyna Kostyrka-Allchorne, Jacqueline Phillips-Owen
We aimed to develop and validate a new scale of future thinking and adolescent mental health—the Adolescent Future Thinking Rating Scale (AFTRS).
-
Prevalence, stability, and predictive utility of the Multidimensional Assessment of Preschoolers Scales clinically optimized irritability score: Pragmatic early assessment of mental disorder risk Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-20 Jillian Lee Wiggins, Ana Ureña Rosario, Leigha A. MacNeill, Sheila Krogh-Jespersen, Margaret Briggs-Gowan, Justin D. Smith, Lauren S. Wakschlag
Characterizing the scope and import of early childhood irritability is essential for real-world actualization of this reliable indicator of transdiagnostic mental health risk. Thus, we utilize pragmatic assessment to establish prevalence, stability, and predictive utility of clinically significant early childhood irritability.
-
Ecological monitoring of emotional intensity, variability, and instability in individuals with schizophrenia spectrum disorders: Results of a multicentre study Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-20 Cristina Zarbo, Manuel Zamparini, Alessandra Patrono, Cosima Calini, Philip D. Harvey, Letizia Casiraghi, Massimo Clerici, Matteo Malvezzi, Matteo Rocchetti, Fabrizio Starace, Giovanni de Girolamo
Evaluating emotional experiences in the life of people with Schizophrenia Spectrum Disorder (SSD) is fundamental for developing interventions aimed at promoting well-being in specific times and contexts. However, little is known about emotional variability in this population. In DiAPAson project, we evaluated between- and within-person differences in emotional intensity, variability, and instability
-
Advancing earlier transdiagnostic identification of mental health risk: A pragmatic approach at the transition to toddlerhood Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-18 Jillian Lee Wiggins, Ana Ureña Rosario, Yudong Zhang, Leigha MacNeill, Qiongru Yu, Elizabeth Norton, Justin D. Smith, Lauren S. Wakschlag
In light of the youth mental health crisis, as 1 in 5 children have a mental disorder diagnosis by age 3, identification of transdiagnostic behavioral vulnerability prior to impairing psychopathology must occur at an earlier phase of the clinical sequence. Here, we lay the groundwork for a pragmatic irritability measure to identify at-risk infant-toddlers.
-
Developmentally specified characterization of the irritability spectrum at early school age: Implications for pragmatic mental health screening Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-15 Emily Hirsch, Tasmia Alam, Nathan Kirk, Katherine B. Bevans, Margaret Briggs-Gowan, Lauren S. Wakschlag, Jillian L. Wiggins, Amy K. Roy
Developmentally specified measures that identify clinically salient irritability are needed for early school-age youth to meaningfully capture this transdiagnostic risk factor for psychopathology. Thus, the current study modeled the normal:abnormal irritability spectrum and generated a clinically optimized screening tool for this population.
-
A pragmatic, clinically optimized approach to characterizing adolescent irritability: Validation of parent- and adolescent reports on the Multidimensional Assessment Profile Scales—Temper Loss Scale Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-13 Nathan Kirk, Emily Hirsch, Tasmia Alam, Lauren S. Wakschlag, Jillian Lee Wiggins, Amy K. Roy
Heightened irritability in adolescence is an impairing symptom that can lead to negative outcomes in adulthood, but effective screening tools are lacking. This study aimed to derive clinically-optimized cutoff scores using the Multidimensional Assessment Profile Scales–Temper Loss (MAPS-TL) to pragmatically identify adolescents with impairing irritability.
-
MAPping affective dimensions of behavior: Methodologic and pragmatic advancement of the Multidimensional Assessment Profiles scales Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-13 Jillian Lee Wiggins, Amy K. Roy, Lauren S. Wakschlag
Rigorous validation of the full developmentally sensitive normal:abnormal spectrum, including evaluating the incremental value of age-specific behaviors, is necessary for nuanced characterization of dimensional features of psychopathology. To maximize the clinical utility of transdiagnostic approaches to risk identification, derivation of psychometrically sound, pragmatic versions with empirically
-
Trial-based economic evaluation of mindfulness-based cognitive therapy compared to treatment as usual for bipolar disorder Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-12 Ben Wijnen, Maud Jansen, Annelieke van Velthoven, Imke Hanssen, Marloes Huijbers, Silvia Evers, Anne Speckens
Aim of this study was to assess the cost-effectiveness and cost-utility of mindfulness-based cognitive therapy (MBCT) and treatment as usual (TAU) compared to TAU alone in adults with Bipolar disorder (BD).
-
Issue Information Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-07
No abstract is available for this article.
-
An exploration of actigraphy in the context of ketamine and treatment-resistant depression Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-09-05 Claire Punturieri, Wallace C. Duncan, Dede Greenstein, Gavi Shandler, Carlos A. Zarate, Jennifer W. Evans
This study explored the potential of non-parametric and complexity analysis metrics to detect changes in activity post-ketamine and their association with depressive symptomatology.
-
Are early post-discharge physician contacts associated with 30-day psychiatric re-hospitalisation? A nationwide claims data based retrospective cohort study in Austria free of immortal time bias Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-08-22 H. Katschnig, C. Straßmayr, F. Endel, M. Posch, I. Steiner
Cost containment and quality of care considerations have increased research interest in the potential preventability of early re-hospitalisations. Various registry-based retrospective cohort studies on psychiatric re-hospitalisation have focused on the role of early post-discharge service contacts, but either did not consider their time-dependent nature (‘immortal time bias’) or evaded the issue by
-
Association of serum brain-derived neurotrophic factor level and early response to antipsychotic drug in first-episode patients with schizophrenia Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-07-23 Tong Zhao, SuFang Tang, XiaoLei Gao, Juan Li, Ran Hao, HaiZhi Chen, GuangBiao Huang
To investigate the role of Brain derived neurotrophic factor (BDNF) in the psychotic symptoms in first-episode patients with schizophrenia and whether BDNF levels were associated with the improvement of psychotic symptoms after risperidone treatment.
-
Do we really need two sessions?: The use of a structured interview as a trauma cue reactivity paradigm Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-07-10 Sarah DeGrace, Pablo Romero-Sanchiz, Igor Yakovenko, Sean P. Barrett, Philip Tibbo, Tessa Cosman, Pars Atasoy, Sherry H. Stewart
Derived from classical conditioning theory and rooted in motivational mechanisms, cue reactivity paradigms (CRPs) are used in addictions research to measure participants' propensities for substance-relevant responses (e.g., craving) during exposure to substance-relevant cues (e.g., drug paraphernalia). CRPs are also useful in PTSD-addiction comorbidity research, allowing the study of affective and
-
Long term outcomes and causal modelling of compulsory inpatient and outpatient mental health care using Norwegian registry data: Protocol for a controversies in psychiatry research project Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-07-08 Tore Hofstad, Olav Nyttingnes, Simen Markussen, Erik Johnsen, Eoin Killackey, David McDaid, Miles Rinaldi, Kimberlie Dean, Beate Brinchmann, Kevin Douglas, Linda Gröning, Stål Bjørkly, Tom Palmstierna, Maria Fagerbakke Strømme, Anne Blindheim, Jorun Rugkåsa, Bjørn Morten Hofmann, Reidar Pedersen, Tarjei Widding-Havneraas, Knut Rypdal, Arnstein Mykletun
Compulsory mental health care includes compulsory hospitalisation and outpatient commitment with medication treatment without consent. Uncertain evidence of the effects of compulsory care contributes to large geographical variations and a controversy on its use. Some argue that compulsion can rarely be justified and should be reduced to an absolute minimum, while others claim compulsion can more frequently
-
Issue Information Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-06-05
No abstract is available for this article.
-
Synchrony in psychotherapy: High physiological positive concordance predicts symptom reduction and negative concordance predicts symptom aggravation Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-05-19 Clara C. Gernert, Afton Nelson, Peter Falkai, Christine M. Falter-Wagner
Therapeutic alliance is often considered as a predictor for therapeutic success. This study explored dyadic synchrony of skin conductance response (SCR) during naturalistic therapeutic interactions and investigated its potential as an objective biomarker for predicting therapy effectiveness.
-
Distress related to psychotic experiences: Enhancing the world health organization composite international diagnostic interview psychosis screen Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-05-17 Hans Oh, Nicole R. Karcher, Nirit Soffer-Dudek, Ai Koyanagi, Megan Besecker, Jordan E. DeVylder
The abbreviated version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) psychosis screen tends to yield high prevalence in online samples. Psychotic Experiences (PE) may not necessarily indicate current or imminent psychopathology; however, distressing PE appear to be more clinically informative.
-
Respondent characteristics associated with adherence in a general population ecological momentary assessment study Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-05-15 Aja Murray, Yi Yang, Xinxin Zhu, Lydia Speyer, Ruth Brown, Manuel Eisner, Denis Ribeaud
Ecological momentary assessment (EMA) has seen an explosion in popularity in recent years; however, an improved understanding of how to minimise (selective) non-adherence is needed.
-
Establishing new cutoffs for Cohen's d: An application using known effect sizes from trials for improving sleep quality on composite mental health Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-04-25 Sareh Panjeh, Anders Nordahl-Hansen, Hugo Cogo-Moreira
Cohen's d conventional effect size cutoffs [small (0.2), medium (0.5), and large (0.8)] might not be representative of the reported distribution of effect sizes across the different areas of health. Effect size cutoffs might vary not only depending on the area of research, but also on the type of intervention and population. That is, they are context dependent. Therefore, we present strategies to redefine
-
Measuring cannabis quantities in online surveys: A rapid review and proposals for ways forward Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-04-23 Jakob Manthey, Maria Teresa Pons-Cabrera, Moritz Rosenkranz, Hugo Lopez-Pelayo
Cannabis use quantities are relevant for determining cannabis-related harms. This research aims to provide an overview of the available methods to assess quantities through self-report.
-
The Major Depression Inventory for diagnosing according to DSM-5 and ICD-11: Psychometric properties and validity in a Swedish general population Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-04-12 Andreas Lundin, Jette Möller, Yvonne Forsell
The Major Depression Inventory (MDI) was constructed to assess DSM-IV and ICD-10 depression symptoms, and does not fully cover the symptoms listed in DSM-5 and ICD-11. This study aimed to augment the MDI to the new diagnostic standards by adding a new item, and to assess and compare the measurement performance of the MDI items and diagnostic algorithms for major depression according to DSM-IV, ICD-10
-
Can neurological soft signs and neurocognitive deficits serve as a combined endophenotype for Han Chinese with bipolar disorder? Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-04-10 Yingying Feng, Jia Song, Guorong Lin, Hong Qian, Li Feng, Zongqin Wang, Juan Wen, Chengchen Wang, Jiayuan Wang, Peifu Li, Zuohui Gao, Xiaoli Wang, Xiaohua Hu
Bipolar disorder's (BD) potential endophenotypes include neurological soft signs (NSS) and neurocognitive disorders (ND). Few research, meanwhile, has coupled NSS and ND as combined endophenotypes of BD.
-
Networks of C-reactive protein and depression symptoms in patients with stable coronary heart disease: Findings from the Heart and Soul Study Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-04-10 Chiyoung Lee, Mary A. Whooley
Research addressing the associations between C-reactive protein (CRP) and depression among patients with stable coronary heart disease (CHD) has produced inconsistent results. This might be attributable to varying associations of CRP with specific depression symptom profiles. We responded to this challenge using various network analysis techniques.
-
Measuring media-related health and mental health information acquisition among Latino adults in the United States Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-03-28 Melissa J. DuPont-Reyes, Alice Villatoro, Giovanni Gama, Lu Tang
We developed and evaluated new media-related health information acquisition measures for U.S.-based Latino populations.
-
The German version of the Revised Children's Anxiety and Depression Scale—Psychometric properties and normative data for German 8- to 17-year-olds Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-03-15 Susanne Grothus, Ariane Sommer, Benedikt B. Claus, Lorin Stahlschmidt, Bruce F. Chorpita, Julia Wager
Anxiety and depression are internalizing mental disorders often commencing in childhood and manifesting in adolescence. The Revised Anxiety and Depression Scale (RCADS) is an internationally widely used standardized diagnostic tool, but the German version has only been validated in a pediatric chronic pain sample; normative data are not available. The aim of this study is to test its reliability (internal
-
Measurement invariance across age, gender, ethnicity, and psychopathology of the Psychotic-Like Experiences Questionnaire for Children in a community sample Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-03-02 Lauren M. Piltz, Emma J. Carpendale, Kristin R. Laurens
The current study aimed to assess the measurement invariance of the 9-item self-report Psychotic-Like Experiences Questionnaire for Children (PLEQ-C) across various demographic (age, gender, ethnicity) and psychopathology profiles in a community sample of children.
-
Issue Information Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-03-01
No abstract is available for this article.
-
Educational level and the risk of mental disorders, substance use disorders and self-harm in different age-groups: A cohort study covering 1,6 million subjects in the Stockholm region Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-02-17 Baojing Li, Peter Allebeck, Bo Burstöm, Anna-Karin Danielsson, Louisa Degenhardt, Terje A. Eikemo, Alize Ferrari, Ann Kristin Knudsen, Andreas Lundin, Hélio Manhica, John Newton, Harvey Whiteford, Pär Flodin, Hugo Sjöqvist, Emilie E. Agardh
To investigate the associations between low education and risk of mental disorders, substance use disorders and self-harm in different age-groups.
-
Differential symptom weighting in estimating empirical thresholds for underlying PTSD severity: Toward a “platinum” standard for diagnosis? Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-02-15 Antonio A. Morgan-López, Lissette M. Saavedra, Denise A. Hien, Sonya B. Norman, Skye S. Fitzpatrick, Ai Ye, Therese K. Killeen, Lesia M. Ruglass, Shannon M. Blakey, Sudie E. Back
Symptom counts as the basis for Post-Traumatic Stress Disorder (PTSD) diagnoses in the DSM presume each symptom is equally reflective of underlying disorder severity. However, the “equal weight” assumption fails to fit PTSD symptom data when tested. The present study developed an enhanced PTSD diagnosis based on (a) a conventional PTSD diagnosis from a clinical interview and (b) an empirical classification
-
Latent anxiety and depression dimensions differ amongst patients with eating disorders: A Swedish nationwide investigation Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-02-12 Christopher Hübel, Andreas Birgegård, Therese Johansson, Liselotte V. Petersen, Rasmus Isomaa, Moritz Herle
Anxiety and depression symptoms are common in individuals with eating disorders. To study these co-occurrences, we need high-quality self-report questionnaires. The 19-item self-rated Comprehensive Psychopathological Rating Scale for Affective Syndromes (CPRS-S-A) is not validated in patients with eating disorders. We tested its factor structure, invariance, and differences in its latent dimensions
-
Mapping length of inpatient treatment duration and year-wise relapse rates in eating disordered populations in a well-defined Western-European healthcare region across 1998–2020 Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-01-30 Peter Andersson, Esmail Jamshidi, Carl-Johan Ekman, Kristina Tedroff, Jonnie Björkander, Magnus Sjögren, Johan Lundberg, Jussi Jokinen, Adrian E. Desai Boström
Updated international guideline recommendations for AN inpatient care rely on expert opinions/observational evidence and promote extended inpatient stays, warranting investigation using higher-level ecological evidence.
-
Harmonizing bifactor models of psychopathology between distinct assessment instruments: Reliability, measurement invariance, and authenticity Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-01-19 Maurício Scopel Hoffmann, Tyler Maxwell Moore, Luiza Kvitko Axelrud, Nim Tottenham, Luis Augusto Rohde, Michael Peter Milham, Theodore Daniel Satterthwaite, Giovanni Abrahão Salum
Model configuration is important for mental health data harmonization. We provide a method to investigate the performance of different bifactor model configurations to harmonize different instruments.
-
Design and field procedures for the clinical reappraisal of the Composite International Diagnostic Interview version 3.3 in Qatar's national mental health study Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-01-18 Iman Amro, Amal Ali, Mohamed H. M. O. Hassan, Mahmoud Al Shawwaf, Ahmed Alhassan, Dalia Al Bahari, Hana El Fakki, Zainab Hijawi, Sheeren Aly, Asmaa Amin, Rumaisa Mohammed, Marwa Nofal, Menatalla Abdelkader, Salma Salman, James Currie, Majid Alabdulla, Nancy A. Sampson, Michael First, Ronald C. Kessler, Peter W. Woodruff, Salma M. Khaled
The Composite International Diagnostic Interview (CIDI) has been clinically reappraised in several studies conducted mainly in the US and Europe. This report describes the methodology used to conduct one of the Middle East's largest clinical reappraisal studies. The study was carried out in conjunction with the World Mental Health Qatar—the first national psychiatric epidemiological study of common
-
Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10-year follow-up community study Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-01-03 Patricia Gracia-García, Juan Bueno-Notivol, Darren M. Lipnicki, Concepción de la Cámara, Antonio Lobo, Javier Santabárbara
There is growing evidence for an association between anxiety and an increased risk of dementia, but it is not clear whether anxiety is a risk factor or a prodromic symptom. In this study, we investigated if clinically significant anxiety increases the risk of developing Alzheimer's disease (AD) up to 10 years later.
-
Psychometrics of the kiddie schedule for affective disorders and schizophrenia present and lifetime version for DSM-5 in Japanese outpatients Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2023-01-02 Takuya Makino, Futoshi Suzuki, Takeshi Nishiyama, Saeko Ishibashi, Hidetaka Nakamichi, Tomoko Iida, Shoko Shimada, Shinji Tomari, Eiji Imanari, Takuma Higashi, Shintaro Fukumoto, Sawa Kurata, Yoshifumi Mizuno, Takuma Kimura, Yukiko Kuru, Takeshi Morimoto, Hirotaka Kosaka
The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL) is a widely used semi-structured diagnostic interview in child and adolescent psychiatry. However, the psychometric properties of its updated version, the K-SADS-PL for DSM-5, have scarcely been examined, especially for criterion validity. This study was designed to examine the inter-rater
-
International monitoring of capacity of treatment systems for alcohol and drug use disorders: Methodology of the Service Capacity Index for Substance Use Disorders Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2022-12-23 Dzmitry Krupchanka, Tomas Formanek, Kevin Shield, Jürgen Rehm, Martijn W. Heymans, Alexandra Fleischmann, Louisa Degenhardt, Tarek Gawad, Vladimir Poznyak
We aimed to develop a Service Capacity Index for Substance Use Disorders (SCI-SUD) that would reflect the capacity of national health systems to provide treatment for alcohol and drug use disorders, in terms of the proportion of available service elements in a given country from a theoretical maximum.
-
Issue Information Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2022-12-04
No abstract is available for this article.
-
Corrigendum Int. J. Meth. Psychiatr. Res. (IF 3.1) Pub Date : 2022-12-04
In the article titled ‘The effect of early cognitive training and rehabilitation for patients with cognitive dysfunction in stroke’ (Xuefang et al., 2021), the corresponding author's mailing address should be changed to: Department of Neurology, Aerospace Center Hospital, No. 15 Yuquan Road, Haidian District, Beijing The Ethics Approval and Consent to Participate section should be updated to: Ethical